[2] Vakker AV. Malignant multifocal ENT tumors[J].Vestn Otorinolaringol, 2002, (2):37-39.
[3] Warren S, Gates O. Multiple primary malignant tumors:a survey of the literature and a statistical study[J].Am J Cancer,1932,16(2):1358-1414.
[4] Panosetti E, Luboinski B, Mamelle G et al. Multiple Synchronous and metachronous cancer of the upper aerodigestive tract:a nine year study[J]. Laryngoscope, 1989, 99(12):1267-1273.
[6] Vilaseca I, Blanch JL, Berenguer J, et al. Transoral laser micro-surgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma:Sixteen years of experience[J].Head Neck, 2016, 38(7):1050-1057.
[7] Wick CC, Rezaee RP, Wang T, et al. Use of concurrent chemoradiation in advanced staged (T4)laryngeal cancer[J].Am J Otolaryngol, 2017, 38(1):72-76.
[9] Lu Z, Sheng J, Zhang Y, et al. Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles[J].J Pathol, 2016, 239(1):72-83.
[12] Conor E, Mark El, Jason R, et al. An update on larynx cancer[J].CA Cancer J Clin, 2017, 67(1):35-50.
[13] Christina K, Christine M, Jakob P, et al. Preliminary insightsinto the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma[J].Sci Rep, 2020, 10(1):16582.
[16] Breheret M, Lubgan D, Haderlein M, et al. Single-cycle induction chemotherapy before chemoradiotherapy or surgery in functionally inoperable head and neck squamous cell carcinoma:10-year results[J].Eur Arch Otorhinolaryngol, 2020, 277(1):245-254.